Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

Eurofins BioPharma Product Testing India Eurofins BioPharma Product Testing India
VS
MENARINI GroupMENARINI Group
Eurofins BioPharma Product Testing India

Eurofins BioPharma Product Testing India

#21 & 22 Phase II Peenya Industrial Area , Bangalore, IN, Bangalore, Karnataka, 560058, IN

Last Update: 31/10/2025

View Profile

Eurofins Biopharma Product Testing India Pvt Ltd, a US FDA inspected lab with NAI (“ZERO” 483) offers GMP testing of drug substance, drug products, intermediates, starting materials and raw materials for Pharmaceutical, Chemical and Food Industries. The state-of-the-art...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:0
Subsidiaries:50
12-month incidents
0
Known data breaches
0
Attack type number
0
MENARINI Group

MENARINI Group

Via dei Sette Santi 1/3, Firenze, 50131, IT

Last Update: 02/04/2026

View Profile
Between 750 and 799
https://www.menarini.com
784/1000Fair

The Menarini Group is a leading international pharmaceutical and diagnostics company, present in 140 countries worldwide, with a turnover of 4,37 Billion euro and more than 17,000 employees. With 9 centers for Research & Development, Menarini’s products are present in ...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:12,720
Subsidiaries:0
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Ranges Comparison

Based On Specific Ai Models Category
Eurofins BioPharma Product Testing India

Eurofins BioPharma Product Testing India

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
MENARINI Group

MENARINI Group

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Eurofins BioPharma Product Testing India in 2026.

Incidents

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for MENARINI Group in 2026.

Incidents

Incident History - Eurofins BioPharma Product Testing India (X = Date, Y = Severity)

Eurofins BioPharma Product Testing India cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - MENARINI Group (X = Date, Y = Severity)

MENARINI Group cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
Eurofins BioPharma Product Testing India

Eurofins BioPharma Product Testing India

Incidents
No explicit notable incidents reported.
MENARINI Group

MENARINI Group

Incidents
No explicit notable incidents reported.

FAQ

Between Eurofins BioPharma Product Testing India company and MENARINI Group company, which one has the best AI Cybersecurity Score ?
Between Eurofins BioPharma Product Testing India company and MENARINI Group company, which one has experienced more cyber incidents in the past ?
Between Eurofins BioPharma Product Testing India company and MENARINI Group company, which one has experienced more cyber incidents this year ?
Between Eurofins BioPharma Product Testing India company and MENARINI Group company, which one has experienced at least one ransomware attack ?
Between Eurofins BioPharma Product Testing India company and MENARINI Group company, which one has experienced at least one data breach ?
Between Eurofins BioPharma Product Testing India company and MENARINI Group company, which one has experienced at least one targeted cyberattack ?
Between Eurofins BioPharma Product Testing India company and MENARINI Group company, which one has experienced at least one vulnerability ?
Between Eurofins BioPharma Product Testing India company and MENARINI Group company, which one holds the most compliance certifications ?
Between Eurofins BioPharma Product Testing India company and MENARINI Group company, which one holds the fewest compliance certifications ?
Between Eurofins BioPharma Product Testing India company and MENARINI Group company, which one has the most subsidiaries ?
Between Eurofins BioPharma Product Testing India company and MENARINI Group company, which one has the largest number of employees ?
Between Eurofins BioPharma Product Testing India and MENARINI Group, which company holds both SOC 2 Type 1 certifications ?
Between Eurofins BioPharma Product Testing India and MENARINI Group, which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - Eurofins BioPharma Product Testing India or MENARINI Group ?
Which company is PCI DSS compliant - Eurofins BioPharma Product Testing India or MENARINI Group ?
Between Eurofins BioPharma Product Testing India and MENARINI Group, which company complies with HIPAA regulations for healthcare data ?
Between Eurofins BioPharma Product Testing India and MENARINI Group, which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-55175
SUMMARY

Spinnaker is an open source, multi-cloud continuous delivery platform. Prior to versions 2026.1.1, 2026.0.3, 2025.4.4, and 2025.3.4 on their respective release lines, Kustomize bake operations allow unsafe YAML tag processing in rosco manifests. This can lead to remote code execution on rosco pods when performing Kustomize bakes. This issue is fixed in versions 2026.1.1, 2026.0.3, 2025.4.4, and 2025.3.4.

PUBLISHED
Date2026-07-10
UPDATED
Date2026-07-10
RISK INFORMATION (Score: 7.5)
CVSS3
Base Score: 7.5
Complexity: HIGH
CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:U/C:H/I:H/A:H
IMPACT SCORE
5.9
EXPLOITABILITY
1.6
CVE-2026-44383
SUMMARY

Multiple connections to the backend using the same charging station ID are allowed, which could allow an attacker to deploy multiple instances of malicious OCPP clients to overwhelm the backend.

PUBLISHED
Date2026-07-10
UPDATED
Date2026-07-10
RISK INFORMATION (Score: 7.5)
CVSS3
Base Score: 7.5
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H
CVSS4
Base Score: 8.7
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:N/VI:N/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.6
EXPLOITABILITY
3.9
CVE-2026-42952
SUMMARY

Previously, there was no throttling on repeated authentication attempts to the charging station backend, which could allow an attacker to execute a denial-of-service attack.

PUBLISHED
Date2026-07-10
UPDATED
Date2026-07-10
RISK INFORMATION (Score: 7.5)
CVSS3
Base Score: 7.5
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:H/A:N
CVSS4
Base Score: 8.7
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:N/VI:H/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.6
EXPLOITABILITY
3.9
CVE-2026-20744
SUMMARY

The charging station websocket endpoint accepts connections without proper authentication, which could lead to privilege escalation.

PUBLISHED
Date2026-07-10
UPDATED
Date2026-07-10
RISK INFORMATION (Score: 9.8)
CVSS3
Base Score: 9.8
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
CVSS4
Base Score: 9.3
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
5.9
EXPLOITABILITY
3.9
CVE-2026-15089
SUMMARY

vulnerability in Drupal Commerce guest registration allows . This issue affects Commerce guest registration versions: *.*.

PUBLISHED
Date2026-07-10
UPDATED
Date2026-07-10
IMPACT SCORE
NA
EXPLOITABILITY
NA